-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
coronavirus
-
Practical Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement
This webinar will give a summary of recently published ESTRO & ASTRO practice guidelines about radiotherapy for lung cancer in the COVID-19 pandemic, whether radiotherapy can or should be adapted, and if so how should this be done. We will address questions about whether radiotherapy can be delayed, fractionation of radiotherapy, multimodality treatment strategies and handling…
-
Member Story: Suraj Samtani Bassarmal
Dr. Suraj Samtani is a medical oncologist living and working in Santiago, Chile. I’m a medical oncologist and I also work in an intensive care unit in Santiago, Chile. In a country where subspecialists have always been on demand, great efforts on how to provide the best care to our patients are being implemented. COVID-19…
-
Grappling with Coronavirus (SARS-CoV-2)
By Corey J. Langer, MD, ILCN Editor Posted: April 16, 2020 Dr. Corey Langer Michele Carbone MD, Ph.D and colleagues have penned a far-ranging editorial, now published online in the Journal of Thoracic Oncology (JTO), on the “Facts, Myths, and Hypotheses” behind this pandemic and global public health crisis, which was first documented in Hubei…
-
Member Story: Dr. Shengxiang Ren
Dr. Shengxiang Ren is an associate professor at Shanghai Pulmonary Hospital, Tongji University and Vice Director at Shanghai Pulmonary Hospital. He is a vice header of interventional section in the Shanghai Medical Association Respiratory Branch and Youth Committee Member in Shanghai Anti-Cancer Association. He is a member of the CTONG Trials Group and participant of…
-
Member Story: Dr. Amy Moore
Dr. Amy Moore—USA Dr. Amy Moore is the Director of Science and Research for the GO2 Foundation for Lung Cancer and based in the San Francisco Bay area, shares her thoughts on the current COVID-19 pandemic and what it means for the lung cancer community. I guess my perspective is a unique one because my doctorate…
-
Member Stories: Dr. Ross Soo
Dr. Ross Soo—Singapore In Singapore, a first confirmed case of COVID-19 was reported in late January and, since then, government measures to contain the first wave of infections have resulted to be effective. As part of a whole national plan to control the outbreak, a timely planning of strategies taken by medical oncologists at the National University…
-
Member Stories: Dr. Brendon Stiles
Dr. Brendon Stiles—USA Dr. Stiles is an Associate Professor of Cardiothoracic Surgery at Weill Cornell Medicine (@WeillCornell) and a thoracic surgeon at NewYork-Presbyterian/Weill Cornell Medical Center (@nyphospital). He is vice-chair of the IASLC Communications Committee and extremely active on Twitter (@BrendonStilesMD). New York City has been hit hard by the pandemic. A lot of what…
-
Member Stories: Dr. Anand Sachithanandan
Dr. Anand Sachithanandan—Kuala Lumpur Dr. Anand Sachithanandan is a consultant cardiothoracic surgeon in private practice in greater Kuala Lumpur. He is co-founder and president of Lung Cancer Network Malaysia, an NGO that aims to improve outcomes from lung cancer through awareness, advocacy and education. Offering a comprehensive portrait of the effects of COVID-19 both on…
-
Member Stories: Dr. Narjust Duma
Dr. Narjust Duma—USA Dr. Narjust Duma is a member of the UW Carbone Cancer Center and Assistant Professor of Medicine in the Division of Hematology, Medical Oncology, and Palliative Care. She graduated first in her medical school class at La Universidad Catolica Nordestana in the Dominican Republic. She then completed her internal medicine residency at…
-
Member Stories: Janet Freeman-Daily
Janet Freeman-Daily—USA Janet is a retired aerospace systems engineer, freelance writer, and metastatic lung cancer patient/activist. Diagnosed in 2011, her focus is now on translating the experience and science of lung cancer for others. She serves as a research advocate for two NCCN facilities, the NCI and other government agencies, and as an Editorial Group…